Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism 4HPPD inhibitors(4-hydroxyphenylpyruvate dioxygenase inhibitors), SPR inhibitors(sepiapterin reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Discovery | - | 02 Oct 2025 | |
| Endocrinology and Metabolic Disease | Discovery | - | 02 Oct 2025 | |
| Hypertension | Discovery | - | 02 Oct 2025 | |
| Nervous System Diseases | Discovery | - | 02 Oct 2025 | |
| Other Diseases | Discovery | - | 02 Oct 2025 |





